Filing Flows › Comparisons › CLDX vs CDIO
Celldex Therapeutics vs Cardio Diagnostics Holdings: CLDX and CDIO compared
Celldex Therapeutics is the larger company: $22K of revenue in its latest quarter (Q2 2026) against $4K for Cardio Diagnostics Holdings (Q3 2026). Cardio Diagnostics Holdings is growing faster (+26% against -97% a year earlier).
Where the money goes: CLDX and CDIO
Celldex Therapeutics (CLDX) · Q2 2026
Celldex Therapeutics, Q2 2026: revenue $22K (-97% year over year), net loss $73.5M, operating cash flow −$57.4M. The chart follows the revenue to costs, profit and cash.
Cardio Diagnostics Holdings (CDIO) · Q3 2026
Cardio Diagnostics Holdings, Q3 2026: revenue $4K (+26% year over year), net loss $1.7M, operating cash flow −$1.5M. The chart follows the revenue to costs, profit and cash.
| Celldex Therapeutics (CLDX) | Cardio Diagnostics Holdings (CDIO) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $22K | $4K |
| Revenue growth, Y/Y | -97% | +26% |
| Operating margin | n/m | n/m |
| Net earnings | −$73.5M | −$1.7M |
| Operating cash flow | −$57.4M | −$1.5M |
Where the revenue comes from
Celldex Therapeutics
- Contracts and grants: $15K (68%)
- Product development and licensing agreements: $7K (32%)
Questions
Which is bigger, Celldex Therapeutics or Cardio Diagnostics Holdings?
Celldex Therapeutics is the larger company: $22K of revenue in its latest quarter (Q2 2026) against $4K for Cardio Diagnostics Holdings (Q3 2026).
Is Celldex Therapeutics or Cardio Diagnostics Holdings growing faster?
Cardio Diagnostics Holdings is growing faster (+26% against -97% a year earlier).
More: Celldex Therapeutics earnings · how Celldex Therapeutics makes money · Cardio Diagnostics Holdings earnings · how Cardio Diagnostics Holdings makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.